Search Within

Anthony R. Martinez Benitez

Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Adult Leukemia (7)
  2. Center for Hematologic Malignancies (7)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  4. Department of Medicine (7)
  5. Executive Committee, Center for Hematologic Malignancies (7)
  6. GSK Faculty (7)

More Groups

People
  1. Ross Levine (7)
  2. Sheng Cai (6)
  3. Young Park (5)
  4. Andrew Dunbar (4)
  5. Ines Fernandez Maestre (4)
  6. Kavi O'Connor (4)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2022 (2)
Publications
  1. Blood (2)
  2. Cancer Discovery (2)
  3. Cancer Cell (1)
  4. Cancer Prevention Research (1)
  5. Experimental Hematology (1)
Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Hematology (2)
  3. Cell Press (1)
  4. Elsevier Science, Inc. (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy
    Journal Article

    Bowman, R. L.; Dunbar, A. J.; Mishra, T.; Xiao, W.; Waarts, M. R.; Maestre, I. F.; Eisman, S. E.; Cai, L.; Mowla, S.; Shah, N.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • CRISPR dependency screens in primary hematopoietic stem cells identify KDM3B as a genotype-specific vulnerability in IDH2- and TET2-mutant cells
    Journal Article

    Waarts, M. R.; Mowla, S.; Boileau, M.; Martinez Benitez, A. R.; Sango, J.; Bagish, M.; Fernández-Maestre, I.; Shan, Y.; Eisman, S. E.; Park, Y. C.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Jak2(V617F) reversible activation shows its essential requirement in myeloproliferative neoplasms
    Journal Article

    Dunbar, A. J.; Bowman, R. L.; Park, Y. C.; O'Connor, K.; Izzo, F.; Myers, R. M.; Karzai, A.; Zaroogian, Z.; Kim, W. J.; Fernandez-Maestre, I.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Targeting JAK1 signaling for molecular prevention in clonal hematopoiesis
    Meeting Abstract

    Vela, P. S.; Wang, R.; Tran, D.; Benitez, A. M.; Krishnan, A.; O'Connor, K.; Liu, W.; Kleppe, M.; Bowman, R.; Cai, S.; more...
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • Targeting JAK1 signaling for molecular prevention in clonal hematopoiesis
    Meeting Abstract

    Sánchez Vela, P.; Benitez, A. M.; Krishnan, A.; Kleppe, M.; Cai, S. F.; Levine, R. L.
    Cancer Prevention Research (2023)

    Fulltext@MSK | Save
  • The second generation type II JAK2 inhibitor, AJ1-10502, demonstrates enhanced selectivity, improved therapeutic efficacy and reduced mutant cell fraction compared to type I JAK2 inhibitors in models of myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Rai, S.; Stetka, J.; Usart, M.; Hao-Shen, H.; Park, Y.; Houston, R.; Martinez Benitez, A. R.; Wereski, M.; Guzzardi, E.; Persaud, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • JAK2(V617F) reversible activation shows an essential requirement for JAK2(V617F) in myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Dunbar, A.; Bowman, R. L.; Park, Y.; Izzo, F.; Myers, R. M.; Karzai, A.; Kim, W. J.; Maestre, I. F.; Waarts, M. R.; Nazir, A.; more...
    Blood (2022)

    Fulltext@MSK | Save